| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.32B | 7.46B | 7.56B | 7.43B | 6.99B | 5.63B |
| Gross Profit | 5.71B | 5.92B | 5.85B | 5.63B | 5.13B | 4.13B |
| EBITDA | 1.36B | 2.02B | 2.05B | 1.92B | 1.63B | 1.24B |
| Net Income | 680.00M | 1.12B | 1.27B | 802.00M | 789.00M | 837.00M |
Balance Sheet | ||||||
| Total Assets | 13.28B | 12.37B | 13.42B | 13.46B | 13.80B | 13.29B |
| Cash, Cash Equivalents and Short-Term Investments | 2.90B | 2.25B | 3.26B | 2.77B | 3.06B | 6.37B |
| Total Debt | 1.95B | 2.22B | 1.95B | 1.95B | 1.96B | 1.95B |
| Total Liabilities | 7.13B | 5.98B | 5.91B | 6.17B | 6.17B | 5.45B |
| Stockholders Equity | 6.15B | 6.39B | 7.51B | 7.29B | 7.63B | 7.84B |
Cash Flow | ||||||
| Free Cash Flow | 2.30B | 1.86B | 2.12B | 1.34B | 1.71B | 1.81B |
| Operating Cash Flow | 2.52B | 2.08B | 2.31B | 1.55B | 1.90B | 1.93B |
| Investing Cash Flow | 0.00 | 37.00M | -207.00M | -217.00M | -2.80B | -505.00M |
| Financing Cash Flow | -2.54B | -2.86B | -1.62B | -1.60B | -1.62B | -15.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $68.48B | 18.20 | 22.14% | 2.19% | 5.69% | 32.87% | |
70 Outperform | $50.95B | 145.12 | 11.05% | 0.37% | -1.45% | -11.99% | |
65 Neutral | $9.49B | 62.04 | 8.04% | ― | 16.84% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | $37.01B | -126.36 | -126.41% | ― | 13.98% | -6.71% | |
52 Neutral | $42.60B | -52.47 | -290.61% | ― | 32.70% | 12.57% | |
50 Neutral | $1.04B | ― | 119.44% | 9.98% | 7.49% | -60.32% |